Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cipargamin (NITD609) 是一种有效的抗疟药物,对恶性疟原虫的IC50值约为 1 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 455 | 现货 | ||
2 mg | ¥ 663 | 现货 | ||
5 mg | ¥ 1,230 | 现货 | ||
10 mg | ¥ 1,980 | 现货 | ||
25 mg | ¥ 3,790 | 现货 | ||
50 mg | ¥ 6,330 | 现货 | ||
100 mg | ¥ 8,550 | 现货 | ||
200 mg | ¥ 11,500 | 现货 | ||
500 mg | ¥ 16,900 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,280 | 现货 |
产品描述 | Cipargamin (NITD609) is an effective antimalarial compound. It has an IC50 of appr 1 nM against P. falciparum. |
靶点活性 | P. falciparum:1 nM |
体外活性 | Cipargamin is the most effective inhibitor of early gametocyte development at 50 and 500 nM. Cipargamin displays a dose-dependent inhibiting effect on late gametocyte development. Cipargamin inhibits T. gondii with an MIC90 for tachyzoites of 5 μM and an MIC50 of 1 μM. At the highest concentration tested (10 μM), It has no toxicity to human foreskin fibroblasts (HFFs). Cipargamin shows effective activities against a panel of culture-adapted P. falciparum strains (IC50: 0.5-1.4 nM). Cipargamin is effective as an artesunate with potency in the low nanomolar range (ICIC50 values consistently <10 nM) against all P. falciparum and P. vivax isolates [1][2][3]. |
体内活性 | Cipargamin (100 mg/kg) fully clears P. berghei infection in all treated mice, and partial cure (50%) is achieved with a single oral dose at 30 mg/kg. Cipargamin displays favorable pharmacokinetic properties and shows single-dose cure efficacy in a malaria mouse model [3]. |
别名 | KAE609, NITD609 |
分子量 | 390.24 |
分子式 | C19H14Cl2FN3O |
CAS No. | 1193314-23-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 0.1 mg/mL (insoluble)
DMSO: 50 mg/mL (128.13 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5625 mL | 12.8126 mL | 25.6253 mL | 64.0631 mL |
5 mM | 0.5125 mL | 2.5625 mL | 5.1251 mL | 12.8126 mL | |
10 mM | 0.2563 mL | 1.2813 mL | 2.5625 mL | 6.4063 mL | |
20 mM | 0.1281 mL | 0.6406 mL | 1.2813 mL | 3.2032 mL | |
50 mM | 0.0513 mL | 0.2563 mL | 0.5125 mL | 1.2813 mL | |
100 mM | 0.0256 mL | 0.1281 mL | 0.2563 mL | 0.6406 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Cipargamin 1193314-23-6 Microbiology/Virology Parasite inhibit KAE609 KAE-609 NITD-609 NITD 609 Inhibitor NITD609 KAE 609 inhibitor